Browsing by Yonsei Author : Chung, Hyun Cheol

Name:
Chung, Hyun Cheol [정현철] http://orcid.org/0000-0002-0920-9471
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)
Scopus ID :
(7404006815)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab ONCOTARGET
2017ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibitionBIOCHEMICAL PHARMACOLOGY
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer ONCOLOGY LETTERS
2017HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib. MOLECULAR CANCER THERAPEUTICS
2017Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracyclineASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2017A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumorsINVESTIGATIONAL NEW DRUGS
2017Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
2017Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer CLINICAL EPIGENETICS
2017PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer ONCOTARGET
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia ANNALS OF SURGERY
2016Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After GastrectomyANNALS OF SURGERY
2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer. CANCER RESEARCH AND TREATMENT
2016Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites ONCOTARGET
2016Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III TrialJOURNAL OF CLINICAL ONCOLOGY
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapyONCOTARGET
2016A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma COLD SPRING HARBOR MOLECULAR CASE STUDIES
2016Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.EXPERIMENTAL AND MOLECULAR PATHOLOGY
2016Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.ANNALS OF NUCLEAR MEDICINE
2016Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trialLANCET ONCOLOGY
2016Prognostic implications of PD-L1 expression in patients with soft tissue sarcomaBMC CANCER
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus ONCOTARGET
2016High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2015Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence? MEDICINE
2015LAMC2 enhances the metastatic potential of lung adenocarcinomaCELL DEATH AND DIFFERENTIATION
2015Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trialLANCET ONCOLOGY
2015Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine CANCER RESEARCH AND TREATMENT
2015PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancerONCOLOGY
2015Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer AMERICAN JOURNAL OF CANCER RESEARCH
2015Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children CANCER RESEARCH AND TREATMENT
2015PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activityINTERNATIONAL JOURNAL OF CANCER
2015The Impact of Coping Styles on Psychological Distress and Quality of Life in Korean Patients with CancerKorean Journal of Psycho-Oncology (정신종양학회지)
2015The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric CancerANNALS OF SURGICAL ONCOLOGY
2015Clinicopathological features and prognostic significance of HER2 expression in gastric cancerONCOLOGY
2015Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancerANNALS OF SURGICAL ONCOLOGY
2014Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START) JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2014Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancerJOURNAL OF PSYCHOSOMATIC RESEARCH
2014Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancerPATHOLOGY
2014A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancerINVESTIGATIONAL NEW DRUGS
2014Quality of Life in the Trastuzumab for Gastric Cancer TrialONCOLOGIST
2014Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2014Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxaneCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.MOLECULAR CANCER THERAPEUTICS
2014Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III StudyJOURNAL OF CLINICAL ONCOLOGY
2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trialINVESTIGATIONAL NEW DRUGS
2014High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients WORLD JOURNAL OF SURGICAL ONCOLOGY
2014Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.LANCET ONCOLOGY
2013Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agentINVESTIGATIONAL NEW DRUGS
2013Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III TrialJOURNAL OF CLINICAL ONCOLOGY
2013Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.NATURE MEDICINE
2013Increased Alternative Lengthening of Telomere Phenotypes of Telomerase-negative Immortal Cells upon Trichostatin – A TreatmentANTICANCER RESEARCH

Browse

Links